standard of care in COVID-19 mild to moderate - Summary of results Outcome TE 95% CI n k I2 ROB Pub. bias deathsdetailed results COALITION I Covid-19 Brazil (AZI, Cavalcanti), 2020 (REV) 2.33 [0.70; 7.77]
2.33 [0.70 ; 7.77 ] COALITION I Covid-19 Brazil (AZI, Cavalcanti), 2020 (REV) 1 0% 331 NA not evaluable clinical improvementdetailed results COALITION I Covid-19 Brazil (AZI, Cavalcanti), 2020 (REV) 1.22 [0.70; 2.13]
1.22 [0.70 ; 2.13 ] COALITION I Covid-19 Brazil (AZI, Cavalcanti), 2020 (REV) 1 0% 331 NA not evaluable clinical improvement (14-day)detailed results COALITION I Covid-19 Brazil (AZI, Cavalcanti), 2020 (REV) 1.22 [0.70; 2.13]
1.22 [0.70 ; 2.13 ] COALITION I Covid-19 Brazil (AZI, Cavalcanti), 2020 (REV) 1 0% 331 NA not evaluable clinical improvement (7-day)detailed results COALITION I Covid-19 Brazil (AZI, Cavalcanti), 2020 (REV) 1.12 [0.74; 1.71]
1.12 [0.74 ; 1.71 ] COALITION I Covid-19 Brazil (AZI, Cavalcanti), 2020 (REV) 1 0% 331 NA not evaluable mechanical ventilationdetailed results COALITION I Covid-19 Brazil (AZI, Cavalcanti), 2020 (REV) 0.65 [0.30; 1.42]
0.65 [0.30 ; 1.42 ] COALITION I Covid-19 Brazil (AZI, Cavalcanti), 2020 (REV) 1 0% 331 NA not evaluable radiologic improvement (14-day)detailed results Rashad A (AZI vs SoC), 2021 (REV) 0.61 [0.35; 1.07]
0.61 [0.35 ; 1.07 ] Rashad A (AZI vs SoC), 2021 (REV) 1 0% 206 NA not evaluable serious adverse eventsdetailed results COALITION I Covid-19 Brazil (AZI, Cavalcanti), 2020 (REV) 0.98 [0.20; 4.92]
0.98 [0.20 ; 4.92 ] COALITION I Covid-19 Brazil (AZI, Cavalcanti), 2020 (REV) 1 0% 438 NA not evaluable adverse eventsdetailed results COALITION I Covid-19 Brazil (AZI, Cavalcanti), 2020 (REV) 0.83 [0.56; 1.23]
0.83 [0.56 ; 1.23 ] COALITION I Covid-19 Brazil (AZI, Cavalcanti), 2020 (REV) 1 0% 438 NA not evaluable renal impairmentdetailed results COALITION I Covid-19 Brazil (AZI, Cavalcanti), 2020 (REV) 0.74 [0.26; 2.12]
0.74 [0.26 ; 2.12 ] COALITION I Covid-19 Brazil (AZI, Cavalcanti), 2020 (REV) 1 0% 331 NA not evaluable 0.2 5.0 1.0 relative treatment effect www.metaEvidence.org 2024-09-28 15:48 +02:00
TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers);
k: number of studies; n: total number of patients;
ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
studied treatment is better when TE > 1;
studied treatment is better when TE < 1;
pathologies: 90
- treatments: 651
- roots T: 651